Yuanshui Zheng
Research Subjects
Yuanshui Zheng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Omar Zeidan
UF Health Cancer Center—Orlando Health, Orlando, FL 32806, USA
3 shared publicationsSameer Keole
2 shared publicationsXiaoning Ding
2 shared publicationsAndries N. Schreuder
1 shared publicationAndries Niek Schreuder
1 shared publicationAnthony Mascia
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 24
Comprehensive and Efficient Validation of Beam Modeling for a Proton Therapy System: Practical Considerations
Introduction: Accurate beam modeling is essential for ensuring safe and effective proton therapy delivery. Before clinical implementation, pencil beam scanning systems require thorough validation to confirm that calculated dose distributions reliably reflect measured performance. This work outlines a practical approach to achieving comprehensive and efficient validation. Methods: The beam model for a pencil beam scanning system was configured in the treatment planning system (TPS). Beam data including integrated depth dose, lateral profiles in air, and absolute outputs for various energies were measured and entered into the TPS following vendor recommendations. Validation tests were performed according to AAPM TG 185 and insights from other proton centers, adapted to our clinical requirements, time constraints, and regulations. The validation incorporated test cases from AAPM TG 350 draft report and included: 1) rectangular field dose distributions in water, 2) PDD measurements, 3) planar dose measurements using the DigiPhant detector with TG 350 test plans and clinical cases, and 4) end-to-end tests in animal tissue. TPS-calculated dose distributions, obtained using either the proton convolution superposition or Acuros Protons algorithms, were compared with corresponding measurements. A peer review from an institute with a similar proton treatment machine validated the machine output and our validation process. Results: For rectangular targets with various ranges and modulation widths in water based on TG 185, TG 350 test plans, and clinical plans, ionization chamber and MatriXX PT planar dose measurements agreed with TPS calculations (point dose difference < 3%, planar dose 3%/3 mm > 95%). Range differences for animal tissues were within 3%. Independent peer output measurements agreed with our results within 1%. Conclusion: TPS-calculated range and dose were in good agreement with measurements across multiple validation tests. The beam model for both PCS and Acuros PT has been validated and used clinically. Incorporating practical considerations is essential for achieving comprehensive and efficient beam commissioning and validation.
- 1 June 2025
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 24
Open AccessComprehensive and Efficient Validation of Beam Modeling for a Proton Therapy System: Practical Considerations
Introduction: Accurate beam modeling is essential for ensuring safe and effective proton therapy delivery. Before clinical implementation, pencil beam scanning systems require thorough validation to confirm that calculated dose distributions reliably reflect measured performance. This work outlines a practical approach to achieving comprehensive and efficient validation. Methods: The beam model for a pencil beam scanning system was configured in the treatment planning system (TPS). Beam data including integrated depth dose, lateral profiles in air, and absolute outputs for various energies were measured and entered into the TPS following vendor recommendations. Validation tests were performed according to AAPM TG 185 and insights from other proton centers, adapted to our clinical requirements, time constraints, and regulations. The validation incorporated test cases from AAPM TG 350 draft report and included: 1) rectangular field dose distributions in water, 2) PDD measurements, 3) planar dose measurements using the DigiPhant detector with TG 350 test plans and clinical cases, and 4) end-to-end tests in animal tissue. TPS-calculated dose distributions, obtained using either the proton convolution superposition or Acuros Protons algorithms, were compared with corresponding measurements. A peer review from an institute with a similar proton treatment machine validated the machine output and our validation process. Results: For rectangular targets with various ranges and modulation widths in water based on TG 185, TG 350 test plans, and clinical plans, ionization chamber and MatriXX PT planar dose measurements agreed with TPS calculations (point dose difference < 3%, planar dose 3%/3 mm > 95%). Range differences for animal tissues were within 3%. Independent peer output measurements agreed with our results within 1%. Conclusion: TPS-calculated range and dose were in good agreement with measurements across multiple validation tests. The beam model for both PCS and Acuros PT has been validated and used clinically. Incorporating practical considerations is essential for achieving comprehensive and efficient beam commissioning and validation.
- Open Access
- 6 February 2017
- Published by Heighten Science Publications Corporation in Journal of Radiology and Oncology
- Vol. 1 (1) , 031-038
Inter-Observer Variability of a Commercial Patient Positioning and Verification System in Proton Therapy
Purpose:Accurate patient positioning is crucial in radiation therapy. To fully benefit from the preciseness of proton therapy, image guided patient positioning and verification system is typically utilized in proton therapy. The purpose of this study is to evaluate the inter-observer variability of image alignment using a commercially available patient positioning and verification system in proton therapy. Methods:The VeriSuite patient positioning and verification system (MedCom GmbH, Darmstadt, Germany) provides a six degrees of freedom correction vector by registering two orthogonal x-ray images to digitally reconstructed radiograph (DRR) images that are rendered in real time from the planning computed tomography (CT) images. Six cases of various disease sites, including brain, head & neck, lung, prostate, pelvis, and bladder, were used in this study. For each case, the planning CT images and a daily orthogonal x-ray portal image pair were loaded into the VeriSuite system. The same set of x-ray images and CT images for each case were reviewed and aligned separately by each of the 10 radiation therapist, following the clinical procedure for the corresponding disease site. The resulting correction vectors were then recorded and analyzed. Results:Our study shows that the inter-observer variation (One standard deviation) in image alignment using the VeriSuite system ranged from 1.2 to 2.0 mm for translational correction and from 0.6 to 1.3 degrees for rotational correction for the six cases. The use of fiducial markers for prostate patient alignment achieved the least inter-observer variation while the bladder case produced the largest. Conclusions:Inter-observer variation in image alignment could be relatively large, depending on the complexity of patient anatomy, image alignment approach, and user experience and software limitations. Automatic registration and fiducial markers could potentially be used to align patient more accurately and consistently. To ensure adequate tumor coverage in proton therapy, inter-observer variability in patient alignment should be carefully evaluated and accounted for in patient setup uncertainty analysis and treatment planning margin determination.
- 6 February 2017
- Published by Heighten Science Publications Corporation in Journal of Radiology and Oncology
- Vol. 1 (1) , 031-038
Open AccessInter-Observer Variability of a Commercial Patient Positioning and Verification System in Proton Therapy
Purpose:Accurate patient positioning is crucial in radiation therapy. To fully benefit from the preciseness of proton therapy, image guided patient positioning and verification system is typically utilized in proton therapy. The purpose of this study is to evaluate the inter-observer variability of image alignment using a commercially available patient positioning and verification system in proton therapy. Methods:The VeriSuite patient positioning and verification system (MedCom GmbH, Darmstadt, Germany) provides a six degrees of freedom correction vector by registering two orthogonal x-ray images to digitally reconstructed radiograph (DRR) images that are rendered in real time from the planning computed tomography (CT) images. Six cases of various disease sites, including brain, head & neck, lung, prostate, pelvis, and bladder, were used in this study. For each case, the planning CT images and a daily orthogonal x-ray portal image pair were loaded into the VeriSuite system. The same set of x-ray images and CT images for each case were reviewed and aligned separately by each of the 10 radiation therapist, following the clinical procedure for the corresponding disease site. The resulting correction vectors were then recorded and analyzed. Results:Our study shows that the inter-observer variation (One standard deviation) in image alignment using the VeriSuite system ranged from 1.2 to 2.0 mm for translational correction and from 0.6 to 1.3 degrees for rotational correction for the six cases. The use of fiducial markers for prostate patient alignment achieved the least inter-observer variation while the bladder case produced the largest. Conclusions:Inter-observer variation in image alignment could be relatively large, depending on the complexity of patient anatomy, image alignment approach, and user experience and software limitations. Automatic registration and fiducial markers could potentially be used to align patient more accurately and consistently. To ensure adequate tumor coverage in proton therapy, inter-observer variability in patient alignment should be carefully evaluated and accounted for in patient setup uncertainty analysis and treatment planning margin determination.
- 25 October 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (22) , 8010-8024
An end-to-end assessment of range uncertainty in proton therapy using animal tissues
Accurate assessment of range uncertainty is critical in proton therapy. However, there is a lack of data and consensus on how to evaluate the appropriate amount of uncertainty. The purpose of this study is to quantify the range uncertainty in various treatment conditions in proton therapy, using transmission measurements through various animal tissues. Animal tissues, including a pig head, beef steak, and lamb leg, were used in this study. For each tissue, an end-to-end test closely imitating patient treatments was performed. This included CT scan simulation, treatment planning, image-guided alignment, and beam delivery. Radio-chromic films were placed at various depths in the distal dose falloff region to measure depth dose. Comparisons between measured and calculated doses were used to evaluate range differences. The dose difference at the distal falloff between measurement and calculation depends on tissue type and treatment conditions. The estimated range difference was up to 5, 6 and 4 mm for the pig head, beef steak, and lamb leg irradiation, respectively. Our study shows that the TPS was able to calculate proton range within about 1.5% plus 1.5 mm. Accurate assessment of range uncertainty in treatment planning would allow better optimization of proton beam treatment, thus fully achieving proton beams' superior dose advantage over conventional photon-based radiation therapy.
- 25 October 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 61 (22) , 8010-8024
An end-to-end assessment of range uncertainty in proton therapy using animal tissues
Accurate assessment of range uncertainty is critical in proton therapy. However, there is a lack of data and consensus on how to evaluate the appropriate amount of uncertainty. The purpose of this study is to quantify the range uncertainty in various treatment conditions in proton therapy, using transmission measurements through various animal tissues. Animal tissues, including a pig head, beef steak, and lamb leg, were used in this study. For each tissue, an end-to-end test closely imitating patient treatments was performed. This included CT scan simulation, treatment planning, image-guided alignment, and beam delivery. Radio-chromic films were placed at various depths in the distal dose falloff region to measure depth dose. Comparisons between measured and calculated doses were used to evaluate range differences. The dose difference at the distal falloff between measurement and calculation depends on tissue type and treatment conditions. The estimated range difference was up to 5, 6 and 4 mm for the pig head, beef steak, and lamb leg irradiation, respectively. Our study shows that the TPS was able to calculate proton range within about 1.5% plus 1.5 mm. Accurate assessment of range uncertainty in treatment planning would allow better optimization of proton beam treatment, thus fully achieving proton beams' superior dose advantage over conventional photon-based radiation therapy.
- 17 May 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part1) , 2904-2910
Minimizing treatment planning errors in proton therapy using failure mode and effects analysis
Purpose: Failure mode and effects analysis (FMEA) is a widely used tool to evaluate safety or reliability in conventional photon radiation therapy. However, reports about FMEA application in proton therapy are scarce. The purpose of this study is to apply FMEA in safety improvement of proton treatment planning at their center.Methods: The authors performed an FMEA analysis of their proton therapy treatment planning process using uniform scanning proton beams. The authors identified possible failure modes in various planning processes, including image fusion, contouring, beam arrangement, dose calculation, plan export, documents, billing, and so on. For each error, the authors estimated the frequency of occurrence, the likelihood of being undetected, and the severity of the error if it went undetected and calculated the risk priority number (RPN). The FMEA results were used to design their quality management program. In addition, the authors created a database to track the identified dosimetric errors. Periodically, the authors reevaluated the risk of errors by reviewing the internal error database and improved their quality assurance program as needed.Results: In total, the authors identified over 36 possible treatment planning related failure modes and estimated the associated occurrence, detectability, and severity to calculate the overall risk priority number. Based on the FMEA, the authors implemented various safety improvement procedures into their practice, such as education, peer review, and automatic check tools. The ongoing error tracking database provided realistic data on the frequency of occurrence with which to reevaluate the RPNs for various failure modes.Conclusions: The FMEA technique provides a systematic method for identifying and evaluating potential errors in proton treatment planning before they result in an error in patient dose delivery. The application of FMEA framework and the implementation of an ongoing error tracking system at their clinic have proven to be useful in error reduction in proton treatment planning, thus improving the effectiveness and safety of proton therapy.
- 17 May 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part1) , 2904-2910
Minimizing treatment planning errors in proton therapy using failure mode and effects analysis
Purpose: Failure mode and effects analysis (FMEA) is a widely used tool to evaluate safety or reliability in conventional photon radiation therapy. However, reports about FMEA application in proton therapy are scarce. The purpose of this study is to apply FMEA in safety improvement of proton treatment planning at their center.Methods: The authors performed an FMEA analysis of their proton therapy treatment planning process using uniform scanning proton beams. The authors identified possible failure modes in various planning processes, including image fusion, contouring, beam arrangement, dose calculation, plan export, documents, billing, and so on. For each error, the authors estimated the frequency of occurrence, the likelihood of being undetected, and the severity of the error if it went undetected and calculated the risk priority number (RPN). The FMEA results were used to design their quality management program. In addition, the authors created a database to track the identified dosimetric errors. Periodically, the authors reevaluated the risk of errors by reviewing the internal error database and improved their quality assurance program as needed.Results: In total, the authors identified over 36 possible treatment planning related failure modes and estimated the associated occurrence, detectability, and severity to calculate the overall risk priority number. Based on the FMEA, the authors implemented various safety improvement procedures into their practice, such as education, peer review, and automatic check tools. The ongoing error tracking database provided realistic data on the frequency of occurrence with which to reevaluate the RPNs for various failure modes.Conclusions: The FMEA technique provides a systematic method for identifying and evaluating potential errors in proton treatment planning before they result in an error in patient dose delivery. The application of FMEA framework and the implementation of an ongoing error tracking system at their clinic have proven to be useful in error reduction in proton treatment planning, thus improving the effectiveness and safety of proton therapy.
- 29 May 2012
- Published by Wiley in Medical Physics
- Vol. 39 (6Part1) , 3484-3492
Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams
Purpose: Neutron exposure is of concern in proton therapy, and varies with beam delivery technique, nozzle design, and treatment conditions. Uniform scanning is an emerging treatment technique in proton therapy, but neutron exposure for this technique has not been fully studied. The purpose of this study is to investigate the neutron dose equivalent per therapeutic dose, H/D, under various treatment conditions for uniform scanning beams employed at our proton therapy center.Methods: Using a wide energy neutron dose equivalent detector (SWENDI‐II, ThermoScientific, MA), the authors measured H/D at 50 cm lateral to the isocenter as a function of proton range, modulation width, beam scanning area, collimated field size, and snout position. They also studied the influence of other factors on neutron dose equivalent, such as aperture material, the presence of a compensator, and measurement locations. They measured H/D for various treatment sites using patient‐specific treatment parameters. Finally, they compared H/D values for various beam delivery techniques at various facilities under similar conditions.Results: H/D increased rapidly with proton range and modulation width, varying from about 0.2 mSv/Gy for a 5 cm range and 2 cm modulation width beam to 2.7 mSv/Gy for a 30 cm range and 30 cm modulation width beam when 18 × 18 cm2 uniform scanning beams were used. H/D increased linearly with the beam scanning area, and decreased slowly with aperture size and snout retraction. The presence of a compensator reduced the H/D slightly compared with that without a compensator present. Aperture material and compensator material also have an influence on neutron dose equivalent, but the influence is relatively small. H/D varied from about 0.5 mSv/Gy for a brain tumor treatment to about 3.5 mSv/Gy for a pelvic case.Conclusions: This study presents H/D as a function of various treatment parameters for uniform scanning proton beams. For similar treatment conditions, the H/D value per uncollimated beam size for uniform scanning beams was slightly lower than that from a passive scattering beam and higher than that from a pencil beam scanning beam, within a factor of 2. Minimizing beam scanning area could effectively reduce neutron dose equivalent for uniform scanning beams, down to the level close to pencil beam scanning.
- 29 May 2012
- Published by Wiley in Medical Physics
- Vol. 39 (6Part1) , 3484-3492
Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams
Purpose: Neutron exposure is of concern in proton therapy, and varies with beam delivery technique, nozzle design, and treatment conditions. Uniform scanning is an emerging treatment technique in proton therapy, but neutron exposure for this technique has not been fully studied. The purpose of this study is to investigate the neutron dose equivalent per therapeutic dose, H/D, under various treatment conditions for uniform scanning beams employed at our proton therapy center.Methods: Using a wide energy neutron dose equivalent detector (SWENDI‐II, ThermoScientific, MA), the authors measured H/D at 50 cm lateral to the isocenter as a function of proton range, modulation width, beam scanning area, collimated field size, and snout position. They also studied the influence of other factors on neutron dose equivalent, such as aperture material, the presence of a compensator, and measurement locations. They measured H/D for various treatment sites using patient‐specific treatment parameters. Finally, they compared H/D values for various beam delivery techniques at various facilities under similar conditions.Results: H/D increased rapidly with proton range and modulation width, varying from about 0.2 mSv/Gy for a 5 cm range and 2 cm modulation width beam to 2.7 mSv/Gy for a 30 cm range and 30 cm modulation width beam when 18 × 18 cm2 uniform scanning beams were used. H/D increased linearly with the beam scanning area, and decreased slowly with aperture size and snout retraction. The presence of a compensator reduced the H/D slightly compared with that without a compensator present. Aperture material and compensator material also have an influence on neutron dose equivalent, but the influence is relatively small. H/D varied from about 0.5 mSv/Gy for a brain tumor treatment to about 3.5 mSv/Gy for a pelvic case.Conclusions: This study presents H/D as a function of various treatment parameters for uniform scanning proton beams. For similar treatment conditions, the H/D value per uncollimated beam size for uniform scanning beams was slightly lower than that from a passive scattering beam and higher than that from a pencil beam scanning beam, within a factor of 2. Minimizing beam scanning area could effectively reduce neutron dose equivalent for uniform scanning beams, down to the level close to pencil beam scanning.
- 31 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 2299-2306
Commissioning of output factors for uniform scanning proton beams
Purpose:: Current commercial treatment planning systems are not able to accurately predict output factors and calculate monitor units for proton fields. Patient‐specific field output factors are thus determined by either measurements or empirical modeling based on commissioning data. The objective of this study is to commission output factors for uniform scanning beams utilized at the ProCure proton therapy centers.Methods:: Using water phantoms and a plane parallel ionization chamber, the authors first measured output factors with a fixed 10 cm diameter aperture as a function of proton range and modulation width for clinically available proton beams with ranges between 4 and 31.5 cm and modulation widths between 2 and 15 cm. The authors then measured the output factor as a function of collimated field size at various calibration depths for proton beams of various ranges and modulation widths. The authors further examined the dependence of the output factor on the scanning area (i.e., uncollimated proton field), snout position, and phantom material. An empirical model was developed to calculate the output factor for patient‐specific fields and the model‐predicted output factors were compared to measurements.Results:: The output factor increased with proton range and field size, and decreased with modulation width. The scanning area and snout position have a small but non‐negligible effect on the output factors. The predicted output factors based on the empirical modeling agreed within 2% of measurements for all prostate treatment fields and within 3% for 98.5% of all treatment fields.Conclusions:: Comprehensive measurements at a large subset of available beam conditions are needed to commission output factors for proton therapy beams. The empirical modeling agrees well with the measured output factor data. This investigation indicates that it is possible to accurately predict output factors and thus eliminate or reduce time‐consuming patient‐specific output measurements for proton treatments.
- 31 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 2299-2306
Commissioning of output factors for uniform scanning proton beams
Purpose:: Current commercial treatment planning systems are not able to accurately predict output factors and calculate monitor units for proton fields. Patient‐specific field output factors are thus determined by either measurements or empirical modeling based on commissioning data. The objective of this study is to commission output factors for uniform scanning beams utilized at the ProCure proton therapy centers.Methods:: Using water phantoms and a plane parallel ionization chamber, the authors first measured output factors with a fixed 10 cm diameter aperture as a function of proton range and modulation width for clinically available proton beams with ranges between 4 and 31.5 cm and modulation widths between 2 and 15 cm. The authors then measured the output factor as a function of collimated field size at various calibration depths for proton beams of various ranges and modulation widths. The authors further examined the dependence of the output factor on the scanning area (i.e., uncollimated proton field), snout position, and phantom material. An empirical model was developed to calculate the output factor for patient‐specific fields and the model‐predicted output factors were compared to measurements.Results:: The output factor increased with proton range and field size, and decreased with modulation width. The scanning area and snout position have a small but non‐negligible effect on the output factors. The predicted output factors based on the empirical modeling agreed within 2% of measurements for all prostate treatment fields and within 3% for 98.5% of all treatment fields.Conclusions:: Comprehensive measurements at a large subset of available beam conditions are needed to commission output factors for proton therapy beams. The empirical modeling agrees well with the measured output factor data. This investigation indicates that it is possible to accurately predict output factors and thus eliminate or reduce time‐consuming patient‐specific output measurements for proton treatments.
- Open Access
- 4 December 2009
- Published by Wiley in Medical Physics
- Vol. 37 (1) , 146-153
Theoretical and empirical investigations of for nearly water‐equivalent radiotherapy dosimetry
Purpose: The low effective atomic number, reusability, and other computed radiography‐related advantages make europium doped potassium chloride a promising dosimetry material. The purpose of this study is to model point dosimeters with a Monte Carlo (MC) method and, using this model, to investigate the dose responses of two‐dimensional (2D) storage phosphor films (SPFs).Methods: point dosimeters were irradiated using a beam at four depths for each of five square field sizes . The dose measured by was compared to that measured by an ionization chamber to obtain the magnitude of energy dependent dose measurement artifact. The measurements were simulated using DOSXYZnrc with phase space files generated by BEAMnrcMP. Simulations were also performed for films with thicknesses ranging from . The work function of the prototype material was determined by comparing the sensitivity of a thick film to a commercial ‐based SPF with a known work function. The work function was then used to estimate the sensitivity of a thick film.Results: The simulated dose responses of prototype point dosimeters agree well with measurement data acquired by irradiating the dosimeters in the beam with varying field size and depth. Furthermore, simulations with films demonstrate that an ultrathin film with thickness of the order of would have nearly water‐equivalent dose response. The simulation results can be understood using classic cavity theories. Finally, preliminary experiments and theoretical calculations show that ultrathin film could provide excellent signal in a dose‐to‐water irradiation.Conclusions: In conclusion, the authors demonstrate that ‐based dosimeters can be accurately modeled by a MC method and that 2D films of the order of thick would have minimal energy dependence. The data support the future research and development of a storage phosphor‐based system for quantitative, high‐resolution multidimensional radiation therapy dosimetry.
- 4 December 2009
- Published by Wiley in Medical Physics
- Vol. 37 (1) , 146-153
Open AccessTheoretical and empirical investigations of for nearly water‐equivalent radiotherapy dosimetry
Purpose: The low effective atomic number, reusability, and other computed radiography‐related advantages make europium doped potassium chloride a promising dosimetry material. The purpose of this study is to model point dosimeters with a Monte Carlo (MC) method and, using this model, to investigate the dose responses of two‐dimensional (2D) storage phosphor films (SPFs).Methods: point dosimeters were irradiated using a beam at four depths for each of five square field sizes . The dose measured by was compared to that measured by an ionization chamber to obtain the magnitude of energy dependent dose measurement artifact. The measurements were simulated using DOSXYZnrc with phase space files generated by BEAMnrcMP. Simulations were also performed for films with thicknesses ranging from . The work function of the prototype material was determined by comparing the sensitivity of a thick film to a commercial ‐based SPF with a known work function. The work function was then used to estimate the sensitivity of a thick film.Results: The simulated dose responses of prototype point dosimeters agree well with measurement data acquired by irradiating the dosimeters in the beam with varying field size and depth. Furthermore, simulations with films demonstrate that an ultrathin film with thickness of the order of would have nearly water‐equivalent dose response. The simulation results can be understood using classic cavity theories. Finally, preliminary experiments and theoretical calculations show that ultrathin film could provide excellent signal in a dose‐to‐water irradiation.Conclusions: In conclusion, the authors demonstrate that ‐based dosimeters can be accurately modeled by a MC method and that 2D films of the order of thick would have minimal energy dependence. The data support the future research and development of a storage phosphor‐based system for quantitative, high‐resolution multidimensional radiation therapy dosimetry.